ICU Medical, Inc. (ICUI)
182.95
+0.71
(+0.39%)
USD |
NASDAQ |
Aug 26, 09:36
ICU Medical Cash from Operations (Quarterly) : 80.15M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.15M |
| March 31, 2026 | 38.91M |
| December 31, 2025 | 60.60M |
| September 30, 2025 | 56.71M |
| June 30, 2025 | 11.21M |
| March 31, 2025 | 51.33M |
| December 31, 2024 | 40.19M |
| September 30, 2024 | 36.10M |
| June 30, 2024 | 81.95M |
| March 31, 2024 | 45.79M |
| December 31, 2023 | 91.27M |
| September 30, 2023 | 35.16M |
| June 30, 2023 | -1.474M |
| March 31, 2023 | 41.24M |
| December 31, 2022 | -1.711M |
| September 30, 2022 | 2.309M |
| June 30, 2022 | -61.38M |
| March 31, 2022 | -1.342M |
| December 31, 2021 | 82.62M |
| September 30, 2021 | 78.84M |
| June 30, 2021 | 54.76M |
| March 31, 2021 | 51.32M |
| December 31, 2020 | 78.53M |
| September 30, 2020 | 75.49M |
| June 30, 2020 | 29.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.52M |
| December 31, 2019 | 48.86M |
| September 30, 2019 | 50.80M |
| June 30, 2019 | 23.27M |
| March 31, 2019 | -21.01M |
| December 31, 2018 | 49.93M |
| September 30, 2018 | 51.32M |
| June 30, 2018 | 79.69M |
| March 31, 2018 | -20.73M |
| December 31, 2017 | 84.55M |
| September 30, 2017 | 98.74M |
| June 30, 2017 | 47.74M |
| March 31, 2017 | -76.61M |
| December 31, 2016 | 21.23M |
| September 30, 2016 | 26.93M |
| June 30, 2016 | 24.48M |
| March 31, 2016 | 17.30M |
| December 31, 2015 | 12.43M |
| September 30, 2015 | 16.69M |
| June 30, 2015 | 12.50M |
| March 31, 2015 | 13.25M |
| December 31, 2014 | 12.29M |
| September 30, 2014 | 19.07M |
| June 30, 2014 | 16.56M |
| March 31, 2014 | 12.71M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Baxter International, Inc. | 285.00M |
| Becton, Dickinson & Co. | 652.00M |
| Boston Scientific Corp. | 1.474B |
| Glaukos Corp. | 14.82M |
| Medline, Inc. | 715.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -20.14M |
| Cash from Financing (Quarterly) | -50.24M |
| Free Cash Flow | 144.84M |
| Free Cash Flow Per Share (Quarterly) | 2.396 |
| Free Cash Flow to Equity (Quarterly) | 114.08M |
| Free Cash Flow to Firm (Quarterly) | 73.67M |
| Free Cash Flow Yield | 3.18% |